Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia.

J Exp Pharmacol · 2022 · PMC9632331 · PMID 36339394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

The trial also demonstrated significant decreases in brain Aβ and tau levels, but improvement was found in regard to most secondary outcomes numerically but failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.